Jun 11, 2024 / 09:00PM GMT
Operator
Greetings and welcome to the Vistagen Therapeutics fiscal year-end 2024 corporate update conference call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mark McPartland, Senior Vice President of Investor Relations.
Mark Mcpartland - Vistagen Therapeutics Inc - Senior Vice President, Investor Relations
Thank you, Joe. Good afternoon, everyone, and welcome to Vistagen's fiscal year-end 2024 corporate update conference call and webcast. This afternoon, we filed our annual report with the Securities and Exchange Commission or SEC, on SEC Form 10-K for our fiscal year ended March 31, 2024, and issued a press release provide an overview of our progress during our fiscal year 2024. We encourage you to review the press release and our 10-K, both of which can be found in the Investors section of our website.
During today's call, we'll make forward-looking statements regarding our business based on our current expectations and information. These forward-looking statements speak
Q4 2024 Vistagen Therapeutics Inc Earnings Call Transcript
Jun 12, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers